CN Stock MarketDetailed Quotes

000028 China National Accord Medicines Corporation

Watchlist
  • 36.60
  • +0.11+0.30%
Noon Break Jun 3 11:30 CST
20.37BMarket Cap12.53P/E (TTM)

China National Accord Medicines Corporation Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
2.16%19.09B
2.77%75.48B
3.61%56.59B
6.25%38.39B
8.96%18.69B
7.44%73.44B
8.78%54.62B
8.94%36.13B
6.86%17.15B
14.60%68.36B
Operating revenue
2.16%19.09B
2.77%75.48B
3.61%56.59B
6.25%38.39B
8.96%18.69B
7.44%73.44B
8.78%54.62B
8.94%36.13B
6.86%17.15B
14.60%68.36B
Other operating revenue
----
-14.71%633.35M
----
6.18%382.39M
----
4.59%742.57M
----
11.90%360.13M
----
36.57%710.01M
Total operating cost
2.54%18.63B
2.76%73.28B
3.41%54.98B
5.99%37.25B
8.15%18.17B
7.20%71.31B
8.75%53.17B
9.14%35.14B
7.24%16.8B
15.05%66.52B
Operating cost
2.80%17.02B
2.96%66.43B
3.53%50.05B
6.25%33.94B
8.71%16.55B
6.92%64.52B
8.99%48.34B
9.32%31.94B
6.78%15.23B
14.73%60.34B
Operating tax surcharges
6.61%45.48M
-2.14%188.18M
-2.31%139.15M
-5.56%90.57M
1.71%42.66M
13.47%192.3M
20.03%142.43M
26.20%95.9M
24.29%41.94M
9.59%169.47M
Operating expense
0.11%1.26B
1.01%5.33B
2.58%3.84B
4.70%2.6B
4.78%1.26B
10.94%5.27B
7.37%3.75B
7.76%2.49B
11.38%1.2B
20.54%4.75B
Administration expense
-5.12%251.65M
-2.03%1.11B
3.49%809.31M
4.17%530.7M
0.27%265.24M
7.98%1.13B
2.89%781.99M
3.44%509.46M
11.33%264.53M
3.72%1.05B
Financial expense
8.10%45.59M
7.93%204.54M
-18.83%124.1M
-33.67%73.76M
-29.53%42.17M
-10.81%189.51M
-7.68%152.89M
3.69%111.2M
18.08%59.84M
77.28%212.48M
-Interest expense (Financial expense)
-7.17%54.75M
-5.16%248.38M
-10.49%183.51M
-24.23%108.24M
-18.67%58.98M
-9.07%261.91M
-7.54%205.02M
-2.85%142.86M
5.58%72.51M
11.56%288.04M
-Interest Income (Financial expense)
-5.69%-19.24M
-6.33%-77.55M
-11.73%-59.4M
-15.86%-40.12M
-8.53%-18.2M
1.83%-72.94M
9.42%-53.17M
10.66%-34.63M
7.13%-16.77M
45.55%-74.3M
Research and development
180.75%6.26M
195.81%26.82M
--17.96M
--12.04M
--2.23M
--9.07M
----
----
----
----
Credit Impairment Loss
14.17%-40.85M
-256.30%-77M
-52.10%-87.28M
-39.41%-61.69M
-83.77%-47.59M
49.50%-21.61M
-81.87%-57.39M
-54.37%-44.25M
-50.60%-25.9M
-64.73%-42.79M
Asset Impairment Loss
27.74%-1.81M
75.45%-17.58M
19.82%-8.65M
61.04%-2.53M
-51.64%-2.51M
70.53%-71.59M
-1,099.11%-10.79M
-1,458.75%-6.5M
52.58%-1.65M
-4,589.93%-242.9M
Other net revenue
45.44%82M
54.70%267.04M
90.53%218.29M
240.00%154.84M
157.10%56.38M
50.96%172.62M
-57.91%114.57M
-73.85%45.54M
-74.06%21.93M
-65.55%114.35M
Fair value change income
----
-152.51%-15.16M
--17.43M
--17.43M
----
--28.87M
----
----
----
----
Invest income
17.13%102.74M
70.36%237.03M
103.50%227.06M
218.09%155.67M
273.86%87.71M
-52.41%139.13M
-51.95%111.58M
-68.75%48.94M
-74.30%23.46M
2.97%292.38M
-Including: Investment income associates
42.41%110.34M
5.67%315.45M
29.98%232.45M
58.72%156.92M
86.33%77.48M
-10.46%298.53M
-24.85%178.84M
-37.30%98.87M
-55.02%41.58M
-5.91%333.4M
Asset deal income
69.31%3.01M
445.31%45.31M
67.65%10.78M
151.82%8.04M
81.57%1.78M
95.71%8.31M
566.74%6.43M
642.26%3.19M
259.86%978.41K
-37.49%4.25M
Other revenue
11.32%18.91M
5.51%94.44M
-8.93%58.95M
-14.12%37.92M
-32.15%16.99M
-13.45%89.51M
-6.82%64.74M
-6.54%44.16M
83.37%25.04M
42.91%103.42M
Operating profit
-5.61%544M
7.00%2.47B
16.54%1.82B
25.45%1.3B
53.66%576.35M
18.11%2.31B
-1.81%1.56B
-9.21%1.03B
-20.42%375.08M
-9.77%1.95B
Add:Non operating Income
137.14%8.15M
96.22%24.45M
-0.28%9.14M
36.02%5.93M
50.18%3.44M
-65.73%12.46M
-43.37%9.16M
-65.13%4.36M
-64.08%2.29M
105.91%36.36M
Less:Non operating expense
46.00%1.9M
150.01%18.65M
189.62%11.61M
328.13%9.38M
116.85%1.3M
-46.42%7.46M
-58.02%4.01M
-32.30%2.19M
5.29%600.91K
-42.62%13.92M
Total profit
-4.88%550.25M
7.02%2.47B
16.00%1.82B
24.85%1.29B
53.54%578.49M
17.02%2.31B
-1.90%1.57B
-9.76%1.03B
-21.04%376.77M
-8.45%1.97B
Less:Income tax cost
-11.50%104.13M
-4.56%514.74M
5.95%370.26M
9.37%262.25M
43.49%117.66M
20.60%539.33M
6.42%349.45M
0.57%239.79M
-6.38%81.99M
2.59%447.21M
Net profit
-3.19%446.12M
10.54%1.96B
18.87%1.45B
29.52%1.03B
56.33%460.83M
15.98%1.77B
-4.05%1.22B
-12.47%794.77M
-24.33%294.77M
-11.25%1.53B
Net profit from continuing operation
-3.19%446.12M
10.54%1.96B
18.87%1.45B
29.52%1.03B
56.33%460.83M
15.98%1.77B
-4.05%1.22B
-12.47%794.77M
-24.33%294.77M
-11.25%1.53B
Less:Minority Profit
-41.85%57.35M
26.03%359.23M
51.20%260.53M
65.20%199.15M
132.55%98.63M
49.06%285.03M
-12.64%172.3M
-27.62%120.55M
-30.20%42.41M
-40.13%191.21M
Net profit of parent company owners
7.33%388.77M
7.57%1.6B
13.56%1.19B
23.14%830.25M
43.53%362.21M
11.24%1.49B
-2.47%1.05B
-9.07%674.22M
-23.25%252.36M
-4.67%1.34B
Earning per share
Basic earning per share
7.69%0.7
7.49%2.87
13.83%2.14
23.14%1.49
10.17%0.65
-14.42%2.67
-25.10%1.88
-30.06%1.21
-23.38%0.59
-4.59%3.12
Diluted earning per share
7.69%0.7
7.49%2.87
13.83%2.14
23.14%1.49
10.17%0.65
-14.42%2.67
-25.10%1.88
-30.06%1.21
-23.38%0.59
-4.59%3.12
Other composite income
100.24%56.31K
-107.43%-9.85K
-160.95%-9.85K
-107.38%-4.77K
15.83%-23.32M
21.42%132.52K
-105.82%-3.77K
-23.47%64.67K
-123.56%-27.71M
Other composite income of parent company owners
----
100.27%38.05K
-107.43%-9.85K
-160.95%-9.85K
-107.38%-4.77K
15.94%-13.96M
21.42%132.52K
-105.82%-3.77K
-23.47%64.67K
-123.41%-16.61M
Other composite income of minority owners
----
100.20%18.26K
----
----
----
15.66%-9.36M
----
----
----
-123.80%-11.1M
Total composite income
-3.19%446.12M
12.02%1.96B
18.86%1.45B
29.52%1.03B
56.30%460.83M
16.57%1.75B
-4.04%1.22B
-12.48%794.77M
-24.33%294.84M
-12.23%1.5B
Total composite income of parent company owners
7.34%388.77M
8.59%1.6B
13.54%1.19B
23.14%830.24M
43.49%362.2M
11.59%1.47B
-2.47%1.05B
-9.08%674.21M
-23.25%252.43M
-5.35%1.32B
Total composite income of minority owners
-41.85%57.35M
30.32%359.25M
51.20%260.53M
65.20%199.15M
132.55%98.63M
53.05%275.67M
-12.64%172.3M
-27.62%120.55M
-30.20%42.41M
-42.72%180.11M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)
--
--
--
Ernst & Young (Special General Partnership)
--
--
--
Ernst & Young (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue 2.16%19.09B2.77%75.48B3.61%56.59B6.25%38.39B8.96%18.69B7.44%73.44B8.78%54.62B8.94%36.13B6.86%17.15B14.60%68.36B
Operating revenue 2.16%19.09B2.77%75.48B3.61%56.59B6.25%38.39B8.96%18.69B7.44%73.44B8.78%54.62B8.94%36.13B6.86%17.15B14.60%68.36B
Other operating revenue -----14.71%633.35M----6.18%382.39M----4.59%742.57M----11.90%360.13M----36.57%710.01M
Total operating cost 2.54%18.63B2.76%73.28B3.41%54.98B5.99%37.25B8.15%18.17B7.20%71.31B8.75%53.17B9.14%35.14B7.24%16.8B15.05%66.52B
Operating cost 2.80%17.02B2.96%66.43B3.53%50.05B6.25%33.94B8.71%16.55B6.92%64.52B8.99%48.34B9.32%31.94B6.78%15.23B14.73%60.34B
Operating tax surcharges 6.61%45.48M-2.14%188.18M-2.31%139.15M-5.56%90.57M1.71%42.66M13.47%192.3M20.03%142.43M26.20%95.9M24.29%41.94M9.59%169.47M
Operating expense 0.11%1.26B1.01%5.33B2.58%3.84B4.70%2.6B4.78%1.26B10.94%5.27B7.37%3.75B7.76%2.49B11.38%1.2B20.54%4.75B
Administration expense -5.12%251.65M-2.03%1.11B3.49%809.31M4.17%530.7M0.27%265.24M7.98%1.13B2.89%781.99M3.44%509.46M11.33%264.53M3.72%1.05B
Financial expense 8.10%45.59M7.93%204.54M-18.83%124.1M-33.67%73.76M-29.53%42.17M-10.81%189.51M-7.68%152.89M3.69%111.2M18.08%59.84M77.28%212.48M
-Interest expense (Financial expense) -7.17%54.75M-5.16%248.38M-10.49%183.51M-24.23%108.24M-18.67%58.98M-9.07%261.91M-7.54%205.02M-2.85%142.86M5.58%72.51M11.56%288.04M
-Interest Income (Financial expense) -5.69%-19.24M-6.33%-77.55M-11.73%-59.4M-15.86%-40.12M-8.53%-18.2M1.83%-72.94M9.42%-53.17M10.66%-34.63M7.13%-16.77M45.55%-74.3M
Research and development 180.75%6.26M195.81%26.82M--17.96M--12.04M--2.23M--9.07M----------------
Credit Impairment Loss 14.17%-40.85M-256.30%-77M-52.10%-87.28M-39.41%-61.69M-83.77%-47.59M49.50%-21.61M-81.87%-57.39M-54.37%-44.25M-50.60%-25.9M-64.73%-42.79M
Asset Impairment Loss 27.74%-1.81M75.45%-17.58M19.82%-8.65M61.04%-2.53M-51.64%-2.51M70.53%-71.59M-1,099.11%-10.79M-1,458.75%-6.5M52.58%-1.65M-4,589.93%-242.9M
Other net revenue 45.44%82M54.70%267.04M90.53%218.29M240.00%154.84M157.10%56.38M50.96%172.62M-57.91%114.57M-73.85%45.54M-74.06%21.93M-65.55%114.35M
Fair value change income -----152.51%-15.16M--17.43M--17.43M------28.87M----------------
Invest income 17.13%102.74M70.36%237.03M103.50%227.06M218.09%155.67M273.86%87.71M-52.41%139.13M-51.95%111.58M-68.75%48.94M-74.30%23.46M2.97%292.38M
-Including: Investment income associates 42.41%110.34M5.67%315.45M29.98%232.45M58.72%156.92M86.33%77.48M-10.46%298.53M-24.85%178.84M-37.30%98.87M-55.02%41.58M-5.91%333.4M
Asset deal income 69.31%3.01M445.31%45.31M67.65%10.78M151.82%8.04M81.57%1.78M95.71%8.31M566.74%6.43M642.26%3.19M259.86%978.41K-37.49%4.25M
Other revenue 11.32%18.91M5.51%94.44M-8.93%58.95M-14.12%37.92M-32.15%16.99M-13.45%89.51M-6.82%64.74M-6.54%44.16M83.37%25.04M42.91%103.42M
Operating profit -5.61%544M7.00%2.47B16.54%1.82B25.45%1.3B53.66%576.35M18.11%2.31B-1.81%1.56B-9.21%1.03B-20.42%375.08M-9.77%1.95B
Add:Non operating Income 137.14%8.15M96.22%24.45M-0.28%9.14M36.02%5.93M50.18%3.44M-65.73%12.46M-43.37%9.16M-65.13%4.36M-64.08%2.29M105.91%36.36M
Less:Non operating expense 46.00%1.9M150.01%18.65M189.62%11.61M328.13%9.38M116.85%1.3M-46.42%7.46M-58.02%4.01M-32.30%2.19M5.29%600.91K-42.62%13.92M
Total profit -4.88%550.25M7.02%2.47B16.00%1.82B24.85%1.29B53.54%578.49M17.02%2.31B-1.90%1.57B-9.76%1.03B-21.04%376.77M-8.45%1.97B
Less:Income tax cost -11.50%104.13M-4.56%514.74M5.95%370.26M9.37%262.25M43.49%117.66M20.60%539.33M6.42%349.45M0.57%239.79M-6.38%81.99M2.59%447.21M
Net profit -3.19%446.12M10.54%1.96B18.87%1.45B29.52%1.03B56.33%460.83M15.98%1.77B-4.05%1.22B-12.47%794.77M-24.33%294.77M-11.25%1.53B
Net profit from continuing operation -3.19%446.12M10.54%1.96B18.87%1.45B29.52%1.03B56.33%460.83M15.98%1.77B-4.05%1.22B-12.47%794.77M-24.33%294.77M-11.25%1.53B
Less:Minority Profit -41.85%57.35M26.03%359.23M51.20%260.53M65.20%199.15M132.55%98.63M49.06%285.03M-12.64%172.3M-27.62%120.55M-30.20%42.41M-40.13%191.21M
Net profit of parent company owners 7.33%388.77M7.57%1.6B13.56%1.19B23.14%830.25M43.53%362.21M11.24%1.49B-2.47%1.05B-9.07%674.22M-23.25%252.36M-4.67%1.34B
Earning per share
Basic earning per share 7.69%0.77.49%2.8713.83%2.1423.14%1.4910.17%0.65-14.42%2.67-25.10%1.88-30.06%1.21-23.38%0.59-4.59%3.12
Diluted earning per share 7.69%0.77.49%2.8713.83%2.1423.14%1.4910.17%0.65-14.42%2.67-25.10%1.88-30.06%1.21-23.38%0.59-4.59%3.12
Other composite income 100.24%56.31K-107.43%-9.85K-160.95%-9.85K-107.38%-4.77K15.83%-23.32M21.42%132.52K-105.82%-3.77K-23.47%64.67K-123.56%-27.71M
Other composite income of parent company owners ----100.27%38.05K-107.43%-9.85K-160.95%-9.85K-107.38%-4.77K15.94%-13.96M21.42%132.52K-105.82%-3.77K-23.47%64.67K-123.41%-16.61M
Other composite income of minority owners ----100.20%18.26K------------15.66%-9.36M-------------123.80%-11.1M
Total composite income -3.19%446.12M12.02%1.96B18.86%1.45B29.52%1.03B56.30%460.83M16.57%1.75B-4.04%1.22B-12.48%794.77M-24.33%294.84M-12.23%1.5B
Total composite income of parent company owners 7.34%388.77M8.59%1.6B13.54%1.19B23.14%830.24M43.49%362.2M11.59%1.47B-2.47%1.05B-9.08%674.21M-23.25%252.43M-5.35%1.32B
Total composite income of minority owners -41.85%57.35M30.32%359.25M51.20%260.53M65.20%199.15M132.55%98.63M53.05%275.67M-12.64%172.3M-27.62%120.55M-30.20%42.41M-42.72%180.11M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)------Ernst & Young (Special General Partnership)------Ernst & Young (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg